About this data
What it is
Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
Who files it
The FTC, which publishes a notice once it and the Department of Justice have granted the request.
How current
We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
Terms
Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
Worth knowing
This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.

This comes from the FTC's list of early-termination notices.

Early terminations granted per month, last 24 months

050100150Dec '24 · Early terminations granted: 0Dec '24Jan '25 · Early terminations granted: 0Feb '25 · Early terminations granted: 0Mar '25 · Early terminations granted: 9Mar '25Apr '25 · Early terminations granted: 17May '25 · Early terminations granted: 32Jun '25 · Early terminations granted: 49Jun '25Jul '25 · Early terminations granted: 35Aug '25 · Early terminations granted: 58Sep '25 · Early terminations granted: 54Sep '25Oct '25 · Early terminations granted: 2Nov '25 · Early terminations granted: 3Dec '25 · Early terminations granted: 122Dec '25Jan '26 · Early terminations granted: 60Feb '26 · Early terminations granted: 48Mar '26 · Early terminations granted: 80Mar '26Apr '26 · Early terminations granted: 89May '26 · Early terminations granted: 37Jun '26 · Early terminations granted: 65Jun '26Jul '26 · Early terminations granted: 65Aug '26 · Early terminations granted: 79Sep '26 · Early terminations granted: 86Sep '26Oct '26 · Early terminations granted: 62Nov '26 · Early terminations granted: 21
050100150Dec '24 · Early terminations granted: 0Dec '24Jan '25 · Early terminations granted: 0Feb '25 · Early terminations granted: 0Mar '25 · Early terminations granted: 9Mar '25Apr '25 · Early terminations granted: 17May '25 · Early terminations granted: 32Jun '25 · Early terminations granted: 49Jun '25Jul '25 · Early terminations granted: 35Aug '25 · Early terminations granted: 58Sep '25 · Early terminations granted: 54Sep '25Oct '25 · Early terminations granted: 2Nov '25 · Early terminations granted: 3Dec '25 · Early terminations granted: 122Dec '25Jan '26 · Early terminations granted: 60Feb '26 · Early terminations granted: 48Mar '26 · Early terminations granted: 80Mar '26Apr '26 · Early terminations granted: 89May '26 · Early terminations granted: 37Jun '26 · Early terminations granted: 65Jun '26Jul '26 · Early terminations granted: 65Aug '26 · Early terminations granted: 79Sep '26 · Early terminations granted: 86Sep '26Oct '26 · Early terminations granted: 62Nov '26 · Early terminations granted: 21

Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.

Latest early terminations granted

Reset

Showing: ticker NVS

Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.

Latest early terminations granted
GrantedBuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it.TransactionSource
Nov 9, 2026Novartis AGBo Ying
Suzhou Abogen Biosciences Co., Ltd; Abogen Life Sciences (Shanghai) C…
20270118FTC ↗
Aug 4, 2026Novartis AGMyricx Pharma Limited20261873FTC ↗
Apr 30, 2026Novartis AGRed Tree Venture Fund, L.P.
Excellergy, Inc.
20261253FTC ↗
Dec 17, 2025Novartis AGAvidity Biosciences, Inc.20260351FTC ↗
Dec 18, 2019Novartis AGThe Medicines Company20200376FTC ↗
Nov 20, 2019Novartis AGPliant Therapeutics, Inc.20200172FTC ↗
Mar 18, 2019Clinigen Group plcNovartis AG
Novartis Vaccines and Diagnostics, Inc.
20190868FTC ↗
Feb 21, 2019Novartis AGIonis Pharmaceuticals, Inc.
Akcea Therapeutics, Inc.
20190748FTC ↗
Aug 20, 2018Mylan N.V.Novartis AG
Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG
20181750FTC ↗
Jan 3, 2018Novartis AGUltragenyx Pharmaceutical Inc.20180490FTC ↗
Dec 8, 2017Novartis AGBioMarin Pharmaceutical Inc.
BioMarin Commerical Limited
20180356FTC ↗
Apr 14, 2017Novartis AGLubris, LLC20171009FTC ↗
Feb 8, 2017Sun Pharmaceutical Industries Ltd.Novartis AG
Novartis Pharma AG
20170582FTC ↗
Jan 12, 2017Novartis AGEncore Vision, Inc.20170496FTC ↗
Jan 12, 2017Novartis AGZiarco Group Limited20170458FTC ↗
Nov 7, 2016Novartis AGSelexys Pharmaceuticals Corporation20170123FTC ↗
Mar 10, 2016Novartis AGTranscend Medical, Inc.20160787FTC ↗
Jul 27, 2015HLS Therapeutics Inc.Novartis AG
Novartis Pharmaceuticals Corporation; Novartis Pharma AG
20151316FTC ↗
Jul 21, 2015Novartis AGSpinifex Pharmaceuticals, Inc.20151262FTC ↗
Dec 19, 2014Eli Lilly and CompanyNovartis AG20140956FTC ↗
Nov 26, 2014GlaxoSmithKline plcNovartis AG
Novartis Vaccines and Diagnostics Pty Ltd; Novartis Vaccines and Diag… and 8 more
20141013FTC ↗
Oct 10, 2014Novartis AGWaveTec Vision Systems, Inc.20141558FTC ↗
Aug 11, 2014Novartis AGGoogle Inc.
Google Asia Pacific Pte. Ltd.; Google Ireland Limited
20141355FTC ↗
Dec 17, 2013Grifols, S.A.Novartis AG
Novartis Pharma AG; Novartis Vaccines and Diagnostics Pty Ltd and 3 more
20140219FTC ↗
Jul 13, 2012Novartis AGFougera S.C.A. SICAR
Fougera Holdings Inc.
20120837FTC ↗
May 4, 2011Meda AB (publ)Novartis AG
Novartis Pharmaceuticals Corporation
20110755FTC ↗
Feb 4, 2011Novartis AGGenoptix, Inc
Genoptix, Inc.
20110518FTC ↗
Oct 12, 2010Warner Chilcott plcNovartis AG
Novartis Pharma AG; Novartis Pharmaceuticals Corporation
20101185FTC ↗
Aug 17, 2010Novartis AGNestle S.A.
Alcon, Inc.
20100346FTC ↗
Jun 19, 2009Novartis AGSchering-Plough Corporation
Schering-Plough Ltd.
20090487FTC ↗
Jun 19, 2009Schering-Plough CorporationNovartis AG
Novartis Pharma AG
20090486FTC ↗
Nov 18, 2008Novartis AGNektar Therapeutics20090096FTC ↗
Jun 1, 2007Novartis AGAntisoma plc
Antisoma Research Limited
20071293FTC ↗
Apr 30, 2007Bayer AGNovartis AG
Novartis Vaccines and Diagnostics, Inc.
20071105FTC ↗
Oct 16, 2006Novartis AGCell Therapeutics, Inc.
Cell Therapeutics Europe S.r.l.
20061867FTC ↗
Aug 31, 2006Novartis AGMomenta Pharmaceuticals, Inc.20061562FTC ↗
Dec 12, 2005Novartis AGTakeda Pharmaceuticals Company, Ltd.
TAK possible match
TAP Pharmaceutical Products Inc.
20060251FTC ↗
Dec 12, 2005Novartis AGAbbott Laboratories
TAP Pharmaceutical Products Inc.
20060250FTC ↗
Dec 5, 2005Novartis AGChiron Corporation20060211FTC ↗
Aug 16, 2005Novartis AGBristol Myers Squibb Company20051327FTC ↗
Jul 19, 2005Novartis AGSanto Holding AG
Eon Labs, Inc.
20050702FTC ↗
Apr 15, 2003Novartis AGIdenix Pharmaceuticals, Inc.20030494FTC ↗
Apr 8, 2003Novartis AGPfizer, Inc.20030482FTC ↗
Jan 31, 2003Watson Pharmaceuticals, Inc.Novartis AG
Novartis Pharma AG; Novartis Pharmaceuticals Corporation
20030286FTC ↗
Nov 22, 2002Guidant CorporationNovartis AG20030088FTC ↗
Aug 24, 2001Novartis AGNovo Nordisk A/S20012292FTC ↗
Jul 30, 2001Novartis AGDr. Reddy's Laboratories Limited20012106FTC ↗
Jun 7, 2001Tyco International, Ltd.Novartis AG
Novartis Corporation
20011859FTC ↗
Nov 14, 2000Novartis AGOrion Corporation20010280FTC ↗
Sep 29, 2000Novartis AGWesley Jessen VisionCare, Inc.20003720FTC ↗

The newest 50 items, most recent first. Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 6:11 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances